EEF2 and Ras-GAP SH3 domain-binding protein (G3BP1) modulate stress granule assembly during HIV-1 infection

Nature Communications

Volumn 5, Issue , 2014, Pages

  Valiente Echeverría, Fernando ^a,b   Melnychuk, Luca ^a,b   Vyboh, Kishanda ^a,b   Ajamian, Lara ^a,b   Gallouzi, Imed Eddine ^b   Bernard, Nicole ^b,c   Mouland, Andrew J ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CYCLOPHILIN A; ELONGATION FACTOR 2; PROTEIN SH3; RAS GAP SH3 DOMAIN BINDING PROTEIN; UNCLASSIFIED DRUG; CARRIER PROTEIN; G3BP PROTEIN, HUMAN; GAG PROTEIN; GREEN FLUORESCENT PROTEIN; PEPTIDE; PROTEIN BINDING; RNA;

ENVIRONMENTAL STRESS; EUKARYOTE; GENETIC ANALYSIS; HOST-PATHOGEN INTERACTION; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; PROTEIN; STABILIZATION; VIRAL DISEASE;

ARTICLE; CELL LYSATE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNITY; IMMUNOFLUORESCENCE; MYRISTYLATION; NONHUMAN; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; STRESS; VIRUS CAPSID; 3T3 CELL LINE; ANIMAL; CELL SEPARATION; CHEMISTRY; CHLOROCEBUS AETHIOPS; COS 1 CELL LINE; FLOW CYTOMETRY; HELA CELL LINE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JURKAT CELL LINE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; MOUSE; PHYLOGENY; PROTEIN TERTIARY STRUCTURE; RNA INTERFERENCE; VIROLOGY;

EUKARYOTA; HUMAN IMMUNODEFICIENCY VIRUS 1; MIRIDAE;

ANIMALS; CARRIER PROTEINS; CELL SEPARATION; CERCOPITHECUS AETHIOPS; CHROMATOGRAPHY, LIQUID; COS CELLS; FLOW CYTOMETRY; GENE PRODUCTS, GAG; GREEN FLUORESCENT PROTEINS; HELA CELLS; HIV INFECTIONS; HIV-1; HUMANS; JURKAT CELLS; MASS SPECTROMETRY; MICE; NIH 3T3 CELLS; PEPTIDES; PHYLOGENY; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RNA; RNA INTERFERENCE;

EID: 84907446937     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms5819     Document Type: Article

References (70)

1. Thomas, M. G., Loschi, M., Desbats, M. A. & Boccaccio, G. L. RNA granules: the good, the bad and the ugly. Cell Signal. 23, 324-334 (2011).
2. Anderson, P. & Kedersha, N. RNA granules: post-transcriptional and epigenetic modulators of gene expression. Nat. Rev. Mol. Cell Biol. 10, 430-436 (2009).
3. Kedersha, N. & Anderson, P. Mammalian stress granules and processing bodies. Methods Enzymol. 431, 61-81 (2007).
4. Fujimura, K., Katahira, J., Kano, F., Yoneda, Y. & Murata, M. Microscopic dissection of the process of stress granule assembly. Biochim. Biophys. Acta 1793, 1728-1737 (2009).
5. Ruggieri, A. et al. Dynamic oscillation of translation and stress granule formation mark the cellular response to virus infection. Cell Host Microbe 12, 71-85 (2012).
6. Ohn, T., Kedersha, N., Hickman, T., Tisdale, S. & Anderson, P. A functional RNAi screen links O-GlcNAc modification of ribosomal proteins to stress granule and processing body assembly. Nat. Cell Biol. 10, 1224-1231 (2008).
7. Tourriere, H. et al. The RasGAP-associated endoribonuclease G3BP assembles stress granules. J. Cell Biol. 160, 823-831 (2003).
8. Gilks, N. et al. Stress granule assembly is mediated by prion-like aggregation of TIA-1. Mol. Biol. Cell 15, 5383-5398 (2004).
9. Wippich, F. et al. Dual specificity kinase DYRK3 couples stress granule condensation/dissolution to mTORC1 signaling. Cell 152, 791-805 (2013).
10. Buchan, J. R., Kolaitis, R. M., Taylor, J. P. & Parker, R. Eukaryotic stress granules are cleared by autophagy and Cdc48/VCP function. Cell 153, 1461-1474 (2013).
11. Coffin, J. M., Hughes, S. H. & Varmus, H. E. in Retroviruses (eds Coffin, J. M., Hughes, S. H. & Varmus, H. E.) (Cold Spring Harbor Laboratory Press, 1997).
12. Abrahamyan, L. G. et al. Novel Staufen1 ribonucleoproteins prevent formation of stress granules but favour encapsidation of HIV-1 genomic RNA. J. Cell Sci. 123, 369-383 (2010).
13. Kedersha, N. L., Gupta, M., Li, W., Miller, I. & Anderson, P. RNA-binding proteins TIA-1 and TIAR link the phosphorylation of eIF-2 alpha to the assembly of mammalian stress granules. J. Cell Biol. 147, 1431-1442 (1999).
14. Mathews, M., Sonenberg, N. & Hershey, J. W. B. Translational Control in Biology and Medicine 3rd edn (Cold Spring Harbor Laboratory Press, 2007).
15. Dang, Y. et al. Eukaryotic initiation factor 2alpha-independent pathway of stress granule induction by the natural product pateamine A. J. Biol. Chem. 281, 32870-32878 (2006).
16. Legros, S. et al. The HTLV-1 Tax protein inhibits formation of stress granules by interacting with histone deacetylase 6. Oncogene 30, 4050-4062 (2011).
17. Valiente-Echeverria, F., Melnychuk, L. & Mouland, A. J. Viral modulation of stress granules. Virus Res. 169, 430-437 (2012).
18. Monette, A., Pante, N. & Mouland, A. J. HIV-1 remodels the nuclear pore complex. J. Cell Biol. 193, 619-631 (2011).
19. Poon, D. T., Chertova, E. N. & Ott, D. E. Human immunodeficiency virus type 1 preferentially encapsidates genomic RNAs that encode Pr55(Gag): functional linkage between translation and RNA packaging. Virology 293, 368-378 (2002).
20. Chatel-Chaix, L. et al. Identification of Staufen in the human immunodeficiency virus type 1 Gag ribonucleoprotein complex and a role in generating infectious viral particles. Mol. Cell. Biol. 24, 2637-2648 (2004).
21. Reil, H., Bukovsky, A. A., Gelderblom, H. R. & Gottlinger, H. G. Efficient HIV-1 replication can occur in the absence of the viral matrix protein. EMBO J. 17, 2699-2708 (1998).
22. Gitti, R. K. et al. Structure of the amino-terminal core domain of the HIV-1 capsid protein. Science 273, 231-235 (1996).
23. Gamble, T. R. et al. Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. Science 278, 849-853 (1997).
24. von Schwedler, U. K., Stray, K. M., Garrus, J. E. & Sundquist, W. I. Functional surfaces of the human immunodeficiency virus type 1 capsid protein. J. Virol. 77, 5439-5450 (2003).
25. von Schwedler, U. K. et al. Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly. EMBO J. 17, 1555-1568 (1998).
26. Tang, C., Ndassa, Y. & Summers, M. F. Structure of the N-terminal 283-residue fragment of the immature HIV-1 Gag polyprotein. Nat. Struct. Biol. 9, 537-543 (2002).
27. Luban, J., Bossolt, K. L., Franke, E. K., Kalpana, G. V. & Goff, S. P. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell 73, 1067-1078 (1993).
28. Liu, Z. et al. The interferon-inducible MxB protein inhibits HIV-1 infection. Cell Host Microbe 14, 398-410 (2013).
29. Kelly, B. N. et al. Implications for viral capsid assembly from crystal structures of HIV-1 Gag(1-278) and CA(N)(133-278). Biochemistry 45, 11257-11266 (2006).
30. Gamble, T. R. et al. Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell 87, 1285-1294 (1996).
31. Soderberg, O. et al. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat. Methods 3, 995-1000 (2006).
32. Gallouzi, I. E. & Steitz, J. A. Delineation of mRNA export pathways by the use of cell-permeable peptides. Science 294, 1895-1901 (2001).
33. Makarow, M. Endocytosis in Saccharomyces cerevisiae: internalization of alpha-amylase and fluorescent dextran into cells. EMBO J. 4, 1861-1866 (1985).
34. Pornillos, O. et al. X-ray structures of the hexameric building block of the HIV capsid. Cell 137, 1282-1292 (2009).
35. Brass, A. L. et al. Identification of host proteins required for HIV infection through a functional genomic screen. Science 319, 921-926 (2008).
36. Chertova, E. et al. Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. J. Virol. 80, 9039-9052 (2006).
37. Fellay, J. et al. A whole-genome association study of major determinants for host control of HIV-1. Science 317, 944-947 (2007).
38. Konig, R. et al. Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 135, 49-60 (2008).
39. Zhou, H. et al. Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe 4, 495-504 (2008).
40. Jager, S. et al. Global landscape of HIV-human protein complexes. Nature 481, 365-370 (2012).
41. Patel, J. et al. Cellular stresses profoundly inhibit protein synthesis and modulate the states of phosphorylation of multiple translation factors. Eur. J. Biochem. 269, 3076-3085 (2002).
42. Cimarelli, A. & Luban, J. Translation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polyprotein. J. Virol. 73, 5388-5401 (1999).
43. Kimball, S. R., Horetsky, R. L., Ron, D., Jefferson, L. S. & Harding, H. P. Mammalian stress granules represent sites of accumulation of stalled translation initiation complexes. Am. J. Physiol. Cell Physiol. 284, C273-C284 (2003).
44. Santos, S., Obukhov, Y., Nekhai, S., Bukrinsky, M. & Iordanskiy, S. Virusproducing cells determine the host protein profiles of HIV-1 virion cores. Retrovirology 9, 65 (2012).
45. Wullner, U. et al. Cell-specific induction of apoptosis by rationally designed bivalent aptamer-siRNA transcripts silencing eukaryotic elongation factor 2. Curr. Cancer Drug Targets 8, 554-565 (2008).
46. Rehman, S. et al. HIV-1 promotes renal tubular epithelial cell protein synthesis: role of mTOR pathway. PLoS ONE 7, e30071 (2012).
47. Folks, T. M. et al. Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc. Natl Acad. Sci. USA 86, 2365-2368 (1989).
48. Braaten, D. et al. Cyclosporine A-resistant human immunodeficiency virus type 1 mutants demonstrate that Gag encodes the functional target of cyclophilin A. J. Virol. 70, 5170-5176 (1996).
49. Franke, E. K. & Luban, J. Inhibition of HIV-1 replication by cyclosporine A or related compounds correlates with the ability to disrupt the Gag-cyclophilin A interaction. Virology 222, 279-282 (1996).
50. Bristow, R. et al. Human cyclophilin has a significantly higher affinity for HIV-1 recombinant p55 than p24. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 20, 334-336 (1999).
51. Le Sage, V., Mouland, A. J. & Valiente-Echeverria, F. Roles of HIV-1 capsid in viral replication and immune evasion. Virus Res. pii S0168-1702, 00276-00277 (2014).
52. Manel, N. et al. A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells. Nature 467, 214-217 (2010).
53. Ramaswami, M., Taylor, J. P. & Parker, R. Altered ribostasis: RNA-protein granules in degenerative disorders. Cell 154, 727-736 (2013).
54. Petrillo, J. E. et al. Cytoplasmic granule formation and translational inhibition of nodaviral RNAs in the absence of the double-stranded RNA binding protein B2. J. Virol. 87, 13409-13421 (2013).
55. Soto-Rifo, R., Rubilar, P. S. & Ohlmann, T. The DEAD-box helicase DDX3 substitutes for the cap-binding protein eIF4E to promote compartmentalized translation initiation of the HIV-1 genomic RNA. Nucleic Acids Res. 41, 6286-6299 (2013).
56. Acheampong, E. A. et al. Combined effects of hyperglycemic conditions and HIV-1 Nef: a potential model for induced HIV neuropathogenesis. Virol. J. 6, 183 (2009).
57. Norman, J. P., Perry, S. W., Kasischke, K. A., Volsky, D. J. & Gelbard, H. A. HIV-1 trans activator of transcription protein elicits mitochondrial hyperpolarization and respiratory deficit, with dysregulation of complex IV and nicotinamide adenine dinucleotide homeostasis in cortical neurons. J. Immunol. 178, 869-876 (2007).
58. Isaguliants, M. et al. Oxidative stress induced by HIV-1 reverse transcriptase modulates the enzyme's performance in gene immunization. Hum. Vaccin. Immunother. 9, 2111-2119 (2013).
59. Castello, A. et al. HIV-1 protease inhibits Cap-and poly(A)-dependent translation upon eIF4GI and PABP cleavage. PLoS ONE 4, e7997 (2009).
60. Xing, S. et al. Increased turnover of FoxP3high regulatory T cells is associated with hyperactivation and disease progression of chronic HIV-1 infection. J. Acquir. Immune Defic. Syndr. 54, 455-462 (2010).
61. Spriggs, K. A., Stoneley, M., Bushell, M. & Willis, A. E. Re-programming of translation following cell stress allows IRES-mediated translation to predominate. Biol. Cell 100, 27-38 (2008).
62. Monette, A. et al. Dual mechanisms of translation initiation of the full-length HIV-1 mRNA contribute to Gag synthesis. PLoS ONE 8, e68108 (2013).
63. Kyei, G. B. et al. Autophagy pathway intersects with HIV-1 biosynthesis and regulates viral yields in macrophages. J. Cell Biol. 186, 255-268 (2009).
64. Waheed, A. A. & Freed, E. O. HIV type 1 Gag as a target for antiviral therapy. AIDS Res. Hum. Retroviruses 28, 54-75 (2012).
65. Li, Y. R., King, O. D., Shorter, J. & Gitler, A. D. Stress granules as crucibles of ALS pathogenesis. J. Cell Biol. 201, 361-372 (2013).
66. Kim, H. J. et al. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature 495, 467-473 (2013).
67. Vyboh, K., Ajamian, L. & Mouland, A. J. Detection of viral RNA by fluorescence in situ hybridization (FISH). J. Vis. Exp. e4002 (2012).
68. Lehmann, M. et al. Intracellular transport of human immunodeficiency virus type 1 genomic RNA and viral production are dependent on dynein motor function and late endosome positioning. J. Biol. Chem. 284, 14572-14585 (2009).
69. Allalou, A. & Wahlby, C. BlobFinder, a tool for fluorescence microscopy image cytometry. Comput. Methods Programs Biomed. 94, 58-65 (2009).
70. Ajamian, L. et al. Unexpected roles for UPF1 in HIV-1 RNA metabolism and translation. RNA 7014, 914-927 (2008).